| Performance evaluation of the LabPET APD-based digital PET scanner M Bergeron, J Cadorette, JF Beaudoin, MD Lepage, G Robert, ... IEEE Transactions on Nuclear Science 56 (1), 10-16, 2009 | 203 | 2009 |
| Microglial priming through the lung–brain axis: The role of air pollution–induced circulating factors CL Mumaw, S Levesque, C McGraw, S Robertson, S Lucas, JE Stafflinger, ... The FASEB Journal 30 (5), 1880, 2016 | 155 | 2016 |
| Alpha-emitters and targeted alpha therapy in oncology: from basic science to clinical investigations M Makvandi, E Dupis, JW Engle, FM Nortier, ME Fassbender, S Simon, ... Targeted oncology 13, 189-203, 2018 | 149 | 2018 |
| 213Bi-[DOTA0, Tyr3] octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model JP Norenberg, BJ Krenning, IRHM Konings, DF Kusewitt, TK Nayak, ... Clinical Cancer Research 12 (3), 897-903, 2006 | 129 | 2006 |
| Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin MP Pai, JP Norenberg, T Anderson, DW Goade, KA Rodvold, RA Telepak, ... Antimicrobial agents and chemotherapy 51 (8), 2741-2747, 2007 | 109 | 2007 |
| Regional particle size dependent deposition of inhaled aerosols in rats and mice PJ Kuehl, TL Anderson, G Candelaria, B Gershman, K Harlin, ... Inhalation toxicology 24 (1), 27-35, 2012 | 108 | 2012 |
| Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis AB Pai, AV Boyd, CR McQuade, A Harford, JP Norenberg, PG Zager Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (3 …, 2007 | 96 | 2007 |
| Somatostatin-receptor-targeted α-emitting 213Bi is therapeutically more effective than β−-emitting 177Lu in human pancreatic adenocarcinoma cells TK Nayak, JP Norenberg, TL Anderson, ER Prossnitz, MG Stabin, ... Nuclear medicine and biology 34 (2), 185-193, 2007 | 94 | 2007 |
| Dynamic imaging of LDH inhibition in tumors reveals rapid in vivo metabolic rewiring and vulnerability to combination therapy N Oshima, R Ishida, S Kishimoto, K Beebe, JR Brender, K Yamamoto, ... Cell reports 30 (6), 1798-1810. e4, 2020 | 88 | 2020 |
| Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients CL Leach, PJ Kuehl, R Chand, L Ketai, JP Norenberg, JD McDonald Annals of Allergy, Asthma & Immunology 108 (3), 195-200, 2012 | 77 | 2012 |
| Preclinical development of a neutral, estrogen receptor–targeted, tridentate 99mTc (I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers TK Nayak, HJ Hathaway, C Ramesh, JB Arterburn, D Dai, LA Sklar, ... Journal of Nuclear Medicine 49 (6), 978-986, 2008 | 57 | 2008 |
| Improved safety and efficacy of 213 Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine HS Chan, MW Konijnenberg, T Daniels, M Nysus, M Makvandi, E de Blois, ... EJNMMI research 6, 1-11, 2016 | 56 | 2016 |
| Linkage Effects on Binding Affinity and Activation of GPR30 and Estrogen Receptors ERα/β with Tridentate Pyridin-2-yl Hydrazine Tricarbonyl−Re/99mTc(I) Chelates C Ramesh, BJ Bryant, T Nayak, CM Revankar, T Anderson, KE Carlson, ... Journal of the American Chemical Society 128 (45), 14476-14477, 2006 | 50 | 2006 |
| A comparison of high-versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro T Nayak, J Norenberg, T Anderson, R Atcher Cancer biotherapy & radiopharmaceuticals 20 (1), 52-57, 2005 | 42 | 2005 |
| Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization KL Aillon, N El-Gendy, C Dennis, JP Norenberg, J McDonald, C Berkland Molecular pharmaceutics 7 (4), 1274-1282, 2010 | 41 | 2010 |
| Pyrazole-based lactate dehydrogenase inhibitors with optimized cell activity and pharmacokinetic properties G Rai, DJ Urban, BT Mott, X Hu, SM Yang, GA Benavides, MS Johnson, ... Journal of medicinal chemistry 63 (19), 10984-11011, 2020 | 31 | 2020 |
| Enhancement of somatostatin-receptor-targeted 177Lu-[DOTA0-Tyr3]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation TK Nayak, RW Atcher, ER Prossnitz, JP Norenberg Nuclear medicine and biology 35 (6), 673-678, 2008 | 30 | 2008 |
| Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate MP Pai, JP Norenberg, RA Telepak, DS Sidney, S Yang Antimicrobial agents and chemotherapy 49 (9), 3784-3788, 2005 | 29 | 2005 |
| Influence of Charge on Cell Permeability and Tumor Imaging of GPR30-Targeted 111In-Labeled Nonsteroidal Imaging Agents TK Nayak, MK Dennis, C Ramesh, R Burai, RW Atcher, LA Sklar, ... ACS chemical biology 5 (7), 681-690, 2010 | 26 | 2010 |
| Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy HS Chan, E de Blois, MW Konijnenberg, A Morgenstern, F Bruchertseifer, ... EJNMMI Radiopharmacy and Chemistry 1, 1-15, 2017 | 22 | 2017 |
Tapan NayakMerckVerified email at merck.com
